Guangzhou LBP Medicine Science & Technology Co., Ltd. (688393.SS)
CNY 28.9
(-2.36%)
CNY 28.9
(-2.36%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 74.97 Million CNY | 18.86% |
| 2022 | 63.07 Million CNY | 55.48% |
| 2021 | 40.56 Million CNY | 61.98% |
| 2020 | 25.04 Million CNY | 21.91% |
| 2019 | 20.54 Million CNY | -13.1% |
| 2018 | 23.64 Million CNY | 23.79% |
| 2017 | 19.09 Million CNY | 18.57% |
| 2016 | 16.1 Million CNY | 0.0% |
| 2013 | 24.85 Million CNY | 107.31% |
| 2012 | 11.98 Million CNY | 146.83% |
| 2011 | 4.85 Million CNY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q3 | 87.26 Million CNY | 0.54% |
| 2024 Q1 | 83.38 Million CNY | 11.22% |
| 2024 Q2 | 86.79 Million CNY | 4.09% |
| 2023 Q2 | 72.84 Million CNY | 2.73% |
| 2023 Q3 | 75.92 Million CNY | 4.23% |
| 2023 Q1 | 70.9 Million CNY | 12.42% |
| 2023 FY | 74.97 Million CNY | 18.86% |
| 2023 Q4 | 74.97 Million CNY | -1.25% |
| 2022 Q2 | 48.7 Million CNY | 5.62% |
| 2022 Q1 | 46.11 Million CNY | 13.67% |
| 2022 FY | 63.07 Million CNY | 55.48% |
| 2022 Q4 | 63.07 Million CNY | 17.53% |
| 2022 Q3 | 53.66 Million CNY | 10.19% |
| 2021 Q1 | 28.13 Million CNY | 12.33% |
| 2021 Q3 | 31.33 Million CNY | 2.31% |
| 2021 FY | 40.56 Million CNY | 61.98% |
| 2021 Q4 | 40.56 Million CNY | 29.48% |
| 2021 Q2 | 30.62 Million CNY | 8.86% |
| 2020 Q4 | 25.04 Million CNY | -12.32% |
| 2020 Q2 | 27.62 Million CNY | 9.6% |
| 2020 Q1 | 25.2 Million CNY | 22.7% |
| 2020 FY | 25.04 Million CNY | 21.91% |
| 2020 Q3 | 28.56 Million CNY | 3.39% |
| 2019 Q2 | 23.92 Million CNY | 0.0% |
| 2019 FY | 20.54 Million CNY | -13.1% |
| 2019 Q4 | 20.54 Million CNY | 0.0% |
| 2018 FY | 23.64 Million CNY | 23.79% |
| 2017 FY | 19.09 Million CNY | 18.57% |
| 2016 FY | 16.1 Million CNY | 0.0% |
| 2014 Q3 | 22.72 Million CNY | 0.0% |
| 2013 FY | 24.85 Million CNY | 107.31% |
| 2012 FY | 11.98 Million CNY | 146.83% |
| 2011 FY | 4.85 Million CNY | 0.0% |